Individuals Discontinuing Weight-Loss Jabs Regain Weight at a Quadrupled Rate Compared to People Using Diet and Exercise

Fresh analysis reveals that people who come off popular slimming jabs like semaglutide or tirzepatide can put back on lost weight much more quickly than those who stop conventional lifestyle regimens.

Research printed in a major health publication points out that while overweight people often shed about a fifth of their body weight while on the medication, the weight is regained at an average rate of nearly a kilo each month upon discontinuation.

"Individuals buying such medications need to be cognizant of the danger of quick weight regain when the therapy concludes," warns researcher Dr. Susan Jebb.

That rate of recovery means a reversion to pre-treatment weight within about one and a half years.

Analyzing Approaches

The analysis, which looked at 37 of trials involving over 9,000 of patients, compared the results of these new drugs with conventional dieting.

Researchers emphasize that individuals who lose weight through diet and exercise generally see a more gradual creep back—approximately 100 grams monthly—post-intervention.

The Reason for the Rapid Rebound

Nutrition scientists propose the mechanism of the jabs accounts for the amplified weight return.

The injections copy a natural hormone called glucagon-like peptide-1, which moderates appetite.

"Sustained high doses of GLP-1 levels far above than normal may cause the system to produce less of its endogenous hormone, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this GLP-1 'fix' means appetite is no longer kept in check, making excessive eating much more probable."

An Ongoing Condition?

Medical guidelines advise the injections for individuals with weight-linked medical conditions, alongside recommended lifestyle changes.

A number of clinicians argue that, considering the likelihood of relapse, the therapy is often ongoing.

This view is echoed by drug manufacturers, who state that the findings "underscore the chronic character of excess weight," akin to managing conditions like hypertension.

User Experiences

Individuals who have come off the medication explain a powerful resurgence of cravings.

"It was like something activating and you become ravenous," said an individual.

This difficulty is exacerbated if patients have not developed sustainable lifestyle or habit modifications during therapy.

Growing Use

Recent estimates indicate that millions of adults in the UK have used these injections in the last 12 months, with demand remaining high.

• Use is higher among women compared to males.
• The middle-aged age group shows the highest usage rates.
• A large proportion obtain the drugs through private healthcare rather than the NHS.

Finally, researchers caution that while these medications are powerful tools for shedding pounds, they are not a permanent solution and long-term success relies on integrated behavioural management.